ATE272617T1 - Sulfonamid-derivate - Google Patents
Sulfonamid-derivateInfo
- Publication number
- ATE272617T1 ATE272617T1 AT01941453T AT01941453T ATE272617T1 AT E272617 T1 ATE272617 T1 AT E272617T1 AT 01941453 T AT01941453 T AT 01941453T AT 01941453 T AT01941453 T AT 01941453T AT E272617 T1 ATE272617 T1 AT E272617T1
- Authority
- AT
- Austria
- Prior art keywords
- sulfonamide derivatives
- psychiatric
- useful
- compound
- formula
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/36—Radicals substituted by singly-bound nitrogen atoms
- C07D213/42—Radicals substituted by singly-bound nitrogen atoms having hetero atoms attached to the substituent nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
- C07C311/02—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
- C07C311/03—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atoms of the sulfonamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C311/05—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atoms of the sulfonamide groups bound to hydrogen atoms or to acyclic carbon atoms to acyclic carbon atoms of hydrocarbon radicals substituted by nitrogen atoms, not being part of nitro or nitroso groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
- C07D235/14—Radicals substituted by nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
- C07D333/20—Radicals substituted by singly bound hetero atoms other than halogen by nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurosurgery (AREA)
- General Health & Medical Sciences (AREA)
- Neurology (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Addiction (AREA)
- Psychology (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Toxicology (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US21136500P | 2000-06-13 | 2000-06-13 | |
PCT/US2001/010840 WO2001096289A1 (en) | 2000-06-13 | 2001-05-30 | Sulfonamide derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE272617T1 true ATE272617T1 (de) | 2004-08-15 |
Family
ID=22786629
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT01941453T ATE272617T1 (de) | 2000-06-13 | 2001-05-30 | Sulfonamid-derivate |
Country Status (9)
Country | Link |
---|---|
US (1) | US6703425B2 (de) |
EP (1) | EP1296945B1 (de) |
JP (1) | JP2004503527A (de) |
AT (1) | ATE272617T1 (de) |
AU (1) | AU2001274806A1 (de) |
CA (1) | CA2411811A1 (de) |
DE (1) | DE60104697T2 (de) |
ES (1) | ES2225558T3 (de) |
WO (1) | WO2001096289A1 (de) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9702194D0 (en) | 1997-02-04 | 1997-03-26 | Lilly Co Eli | Sulphonide derivatives |
US6639107B1 (en) | 1999-12-08 | 2003-10-28 | Eli Lilly And Company | Cyclopentyl sulfonamide derivatives |
CA2543918A1 (en) * | 2003-10-28 | 2005-05-12 | Dean Wilson | Benzimidazoles useful as modulators of ion channels |
RU2403242C2 (ru) | 2004-08-09 | 2010-11-10 | Глэксо Груп Лимитед | Соединения, которые усиливают рецептор глутамата, и их применение в медицине |
US8007849B2 (en) * | 2005-12-14 | 2011-08-30 | International Flavors & Fragrances Inc. | Unsaturated cyclic and acyclic carbamates exhibiting taste and flavor enhancement effect in flavor compositions |
EP1981865A1 (de) * | 2006-02-08 | 2008-10-22 | Glaxo Group Limited | 4-phenyl-3-(2-propylsulfonylamino)tetrahydrofuranderivate, die glutamatrezeptoren verstärken und sich für die behandlung von schizophrenie eignen |
US20070293573A1 (en) * | 2006-02-24 | 2007-12-20 | Eric Gouaux | Glu2 receptor modulators |
US20090270508A1 (en) * | 2007-02-23 | 2009-10-29 | James Eric Gouaux | GluR2 receptor modulators |
UA103319C2 (en) | 2008-05-06 | 2013-10-10 | Глаксосмитклайн Ллк | Thiazole- and oxazole-benzene sulfonamide compounds |
WO2011109398A2 (en) | 2010-03-02 | 2011-09-09 | President And Fellows Of Harvard College | Methods and compositions for treatment of angelman syndrome and autism spectrum disorders |
JP2016521755A (ja) | 2013-06-13 | 2016-07-25 | ヴェロサイエンス,リミテッド・ライアビリティー・カンパニー | 代謝障害を治療するための組成物および方法 |
CN109678812B (zh) * | 2018-12-30 | 2022-09-02 | 天津大学 | 一种5-乙烯基-2-硫代恶唑烷的制备方法 |
EP4201978A4 (de) | 2020-08-20 | 2024-02-14 | Mitsubishi Gas Chemical Co | Polyamidharz |
WO2022038865A1 (ja) | 2020-08-20 | 2022-02-24 | 三菱瓦斯化学株式会社 | ポリアミド樹脂 |
JPWO2022215494A1 (de) | 2021-04-08 | 2022-10-13 | ||
JP7235184B1 (ja) | 2021-04-26 | 2023-03-08 | 三菱瓦斯化学株式会社 | 化合物及びその製造方法 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PL321634A1 (en) | 1995-02-01 | 1997-12-08 | Upjohn Co | 2-aminoindanes as selective ligands of dopamine receptor d3 |
GB9702194D0 (en) | 1997-02-04 | 1997-03-26 | Lilly Co Eli | Sulphonide derivatives |
JP3817045B2 (ja) * | 1997-09-12 | 2006-08-30 | 四国化成工業株式会社 | 溶融塩型高分子電解質 |
AU741742B2 (en) | 1998-02-24 | 2001-12-06 | Eli Lilly And Company | Sulphonamide derivatives |
CA2338994A1 (en) | 1998-07-31 | 2000-02-10 | Paul Leslie Ornstein | Sulfonamide derivatives |
CA2409830A1 (en) | 2000-05-19 | 2001-11-29 | Macklin Brian Arnold | Sulfonamide derivatives |
ES2249433T3 (es) | 2000-05-19 | 2006-04-01 | Eli Lilly And Company | Procedimiento de preparacion de compuestos de bifenol. |
-
2001
- 2001-05-30 EP EP01941453A patent/EP1296945B1/de not_active Expired - Lifetime
- 2001-05-30 US US10/276,738 patent/US6703425B2/en not_active Expired - Fee Related
- 2001-05-30 AU AU2001274806A patent/AU2001274806A1/en not_active Abandoned
- 2001-05-30 JP JP2002510433A patent/JP2004503527A/ja not_active Withdrawn
- 2001-05-30 WO PCT/US2001/010840 patent/WO2001096289A1/en active IP Right Grant
- 2001-05-30 CA CA002411811A patent/CA2411811A1/en not_active Abandoned
- 2001-05-30 DE DE60104697T patent/DE60104697T2/de not_active Expired - Fee Related
- 2001-05-30 AT AT01941453T patent/ATE272617T1/de not_active IP Right Cessation
- 2001-05-30 ES ES01941453T patent/ES2225558T3/es not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
ES2225558T3 (es) | 2005-03-16 |
US6703425B2 (en) | 2004-03-09 |
WO2001096289A1 (en) | 2001-12-20 |
DE60104697T2 (de) | 2005-08-04 |
AU2001274806A1 (en) | 2001-12-24 |
EP1296945B1 (de) | 2004-08-04 |
EP1296945A1 (de) | 2003-04-02 |
US20030229102A1 (en) | 2003-12-11 |
JP2004503527A (ja) | 2004-02-05 |
DE60104697D1 (de) | 2004-09-09 |
CA2411811A1 (en) | 2001-12-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60104697D1 (de) | Sulfonamid-derivate | |
FI950309A0 (fi) | Proliiniamidijohdannaisia | |
AP2002002637A0 (en) | Novel piperazine | |
GC0000375A (en) | Benzodiazepine derivatives as gaba a receptor modulators | |
EA200300982A1 (ru) | Гетероциклические производные для лечения рака и других пролиферативных заболеваний | |
YU94103A (sh) | Novi derivati sulfonske kiseline | |
DE60120427D1 (de) | Radicicol und monocillin und ihre analogen und ihre anwendungen | |
ID24846A (id) | Turunan-turunan bifenilamidina | |
AP2001002306A0 (en) | Bridged piperazine derivatives. | |
CY1108837T1 (el) | ΝΕΑ ΠΑΡΑΓΩΓΑ ΑΜΙΝΟΠΥΡΙΔΙΝΗΣ ΩΣ ΑΝΤΑΓΩΝΙΣΤΕΣ mGluR5 | |
EA200201232A1 (ru) | Производные сульфонамида | |
EA200201234A1 (ru) | Производные сульфонамида | |
ATE298742T1 (de) | Zykloalkenylsulfonamidderivate | |
AP2002002595A0 (en) | Heterocyclic amide derivatives. | |
DK1049672T3 (da) | Azetidincarboxamid-derivater til behandling af CNS-lidelser | |
DE60211866D1 (de) | Thiophen substituierte amin derivate als glyt-1 inhibitoren | |
DK1049670T3 (da) | Azetidincarboxamidderivater til behandling af CNS-lidelser | |
EA200501053A1 (ru) | Производные 1,2,4-триаминобензола, пригодные для лечения расстройств центральной нервной системы |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |